In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents

被引:194
|
作者
Almyroudis, Nikolaos G.
Sutton, Deanna A.
Fothergill, Annette W.
Rinaldi, Michael G.
Kusne, Shimon
机构
[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY USA
[2] Dept Pathol, Fungus Testing Lab, San Antonio, TX USA
[3] Audie L Murphy Mem Vet Adm Med Ctr, S Texas Vet Hlth Care Syst, San Antonio, TX USA
[4] Mayo Clin, Phoenix, AZ USA
关键词
D O I
10.1128/AAC.00452-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We evaluated the in vitro susceptibilities of 217 zygomycetes to amphotericin B, ketoconazole, fluconazole, itraconazole, voriconazole, posaconazole, caspofungin, and flucytosine. The significant in vitro activity of posaconazole against several species appears to support its reported clinical efficacy. Decreased susceptibility to amphotericin B was noted with Cunninghamella bertholletiae.
引用
收藏
页码:2587 / 2590
页数:4
相关论文
共 50 条
  • [21] IN-VITRO SUSCEPTIBILITY TO 9 ANTIFUNGAL AGENTS OF 14 STRAINS OF ZYGOMYCETES ISOLATED FROM CLINICAL SPECIMENS
    OTCENASEK, M
    BUCHTA, V
    MYCOPATHOLOGIA, 1994, 128 (03) : 135 - 137
  • [22] The susceptibilities to antifungal agents and drug resistance mechanisms of vaginal yeast isolates
    Cernicka, J
    Sojakova, M
    Liptajova, A
    Borovsky, M
    Subik, J
    Multidisciplinarity for Parasites, Vectors and Parasitic Diseases, Vol 2, 2004, : 393 - 397
  • [23] IN VITRO ACTIVITY OF CONVENTIONAL ANTIFUNGAL AGENTS AGAINST SCEDOSPORIUM APIOSPERMUM ISOLATES RECOVERED FROM CLINICAL AND ENVIRONMENTAL SAMPLES IN NIGERIA
    Nweze, E. I.
    Okafor, J. I.
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2010, 57 (03) : 209 - 214
  • [24] Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates
    Barchiesi, F
    Tortorano, AM
    Di Francesco, LF
    Rigoni, A
    Giacometti, A
    Spreghini, E
    Scalise, G
    Viviani, MA
    JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (03) : 279 - 285
  • [25] In vitro susceptibilities of ocular isolates in fungal keratitis to posaconazole, a new triazole antifungal agent.
    Hu, G
    Yi, S
    Roberts, BC
    Hayes, CE
    Schell, WA
    Perfect, JR
    Fowler, WC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S580 - S580
  • [26] In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
    Cordoba, Susana
    Rodero, Laura
    Vivot, Walter
    Abrantes, Ruben
    Davel, Graciela
    Vitale, Roxana G.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (02) : 171 - 174
  • [27] In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus
    Alastruey-Izquierdo, Ana
    Cuesta, Isabel
    Houbrakent, Jos
    Cuenca-Estrella, Manuel
    Monzon, Araceli
    Rodriguez-Tudela, Juan L.
    MEDICAL MYCOLOGY, 2010, 48 (01) : 97 - 102
  • [28] In Vitro Activities of Antifungal Agents against Clinical Isolates of Dermatophytes from Animals
    Itoi, Sayuri
    Kano, Rui
    Hasegawa, Atsuhiko
    Kamata, Hiroshi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2012, 74 (08): : 1067 - 1069
  • [29] In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae
    Barchiesi, F
    Arzeni, D
    Compagnucci, P
    Di Francesco, LF
    Giacometti, A
    Scalise, G
    MEDICAL MYCOLOGY, 1998, 36 (06) : 437 - 440
  • [30] SUSCEPTIBILITY OF CLINICAL ISOLATES OF YEASTS TO ANTIFUNGAL AGENTS
    QADRI, SMHH
    FLOURNOY, DJ
    QADRI, SGM
    RAMIREZ, EG
    MYCOPATHOLOGIA, 1986, 95 (03) : 183 - 187